Cerebrospinal fluid proteomic patterns discriminate Parkinson's disease and multiple system atrophy

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

(2011) Brit Mollenhauer et al.   LANCET NEUROLOGY

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

(2010) Min Shi et al.   ANNALS OF NEUROLOGY

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach

(2010) Karin D. van Dijk et al.   NEUROBIOLOGY OF DISEASE

Proteomic profiling of cerebrospinal fluid in parkinsonian disorders

(2010) Radu Constantinescu et al.   PARKINSONISM & RELATED DISORDERS

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Multiple system atrophy: an update

(2009) Nadia Stefanova et al.   LANCET NEUROLOGY

Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

(2009) David J. Brooks et al.   MOVEMENT DISORDERS

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Dimensionality Reduction and Visualization in Principal Component Analysis

(2008) Gordana Ivosev et al.   ANALYTICAL CHEMISTRY

Second consensus statement on the diagnosis of multiple system atrophy

(2008) S. Gilman et al.   NEUROLOGY

Human urine biomarkers of renal cell carcinoma evaluated by ClinProt

(2008) Niccolò Bosso et al.   Proteomics Clinical Applications